Sudden death in heart failure

[1]  M. Glikson,et al.  The implantable cardioverter defibrillator , 2001, The Lancet.

[2]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[3]  L. Bing Liem D.O.,et al.  Implantable Cardioverter-Defibrillator , 2001, Springer Netherlands.

[4]  B. Greenberg,et al.  Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management , 2000 .

[5]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[6]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[7]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[8]  A. Camm,et al.  901–41 Preliminary Mortality Results from the Survival with Oral D-Sotalol (SWORD) Trial , 1995 .

[9]  F. Morady,et al.  Catheter ablation of ventricular tachycardia. , 1995, Current opinion in cardiology.

[10]  L. Wilkins.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[11]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[12]  J. Ruskin,et al.  Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. , 1994, Circulation.

[13]  G. Hindricks,et al.  Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. , 1994, European heart journal.

[14]  W. Stevenson,et al.  Sudden Death Prevention in Patients With Advanced Ventricular Dysfunction , 1993, Circulation.

[15]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[16]  J. Magovern,et al.  Operation for congestive heart failure: transplantation, coronary artery bypass, and cardiomyoplasty. , 1993, The Annals of thoracic surgery.

[17]  J. Ruskin,et al.  Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. , 1993, Circulation.

[18]  J. Cohn,et al.  Enalapril Decreases Prevalence of Ventricular Tachycardia in Patients With Chronic Congestive Heart Failure , 1993, Circulation.

[19]  M. Borggrefe,et al.  Do patients with an implantable defibrillator live longer? , 1993, Journal of the American College of Cardiology.

[20]  J. Cohn,et al.  Mechanism of Death in Heart Failure The Vasodilator‐Heart Failure Trials , 1993, Circulation.

[21]  A. Woelfel,et al.  Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. , 1993, The American journal of cardiology.

[22]  George A. Johnson,et al.  Implantable transvenous cardioverter-defibrillators. , 1993, Circulation.

[23]  F. Marchlinski,et al.  Shock Occurrence and Survival in 241 Patients With Implantable Cardioverter‐ Defibrillator Therapy , 1993, Circulation.

[24]  H. Greene.  Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. , 1993, The American journal of cardiology.

[25]  C. Chiang,et al.  Reversibility of left ventricular dysfunction after successful catheter ablation of supraventricular reentrant tachycardia. , 1992, American heart journal.

[26]  G. Steinbeck,et al.  A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. , 1992, The New England journal of medicine.

[27]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[28]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[29]  R. Kronmal,et al.  Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1992, Journal of the American College of Cardiology.

[30]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[31]  G. Breithardt,et al.  Role of Ventricular Tachycardia Surgery and Catheter Ablation As Complements or Alternatives To the Implantable Cardioverter Defibrillator in the 1990s , 1992, Pacing and clinical electrophysiology : PACE.

[32]  T. Meinertz,et al.  Prevalence, Circumstances, Mechanisms, and Risk Stratification of Sudden Cardiac Death in Unipolar Single‐Chamber Ventricular Pacing , 1992, Circulation.

[33]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[34]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[35]  L. Stevenson,et al.  Cardiac transplantation as therapy for heart failure. , 1991, Current problems in cardiology.

[36]  B. Brembilla-Perrot,et al.  Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. , 1991, American heart journal.

[37]  P. J. Wang,et al.  Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. , 1991, American heart journal.

[38]  W. Stevenson,et al.  Impact of vasodilator regimen on sudden death in advanced heart failure: A randomized trial of angiotensin-converting-enzyme inhibition and direct vasodilation , 1991 .

[39]  P. Tchou,et al.  Survival in Patients with Depressed Left Ventricular Function Treated by Implantable Cardioverter Defibrillator , 1991, Pacing and clinical electrophysiology : PACE.

[40]  J. Brachmann,et al.  Heart Failure and Arrhythmias , 1990, Springer Berlin Heidelberg.

[41]  P Smith,et al.  The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.

[42]  J. Kjekshus.  Arrhythmias and mortality in congestive heart failure. , 1990, The American journal of cardiology.

[43]  J. Guindo,et al.  Treatment of heart failure: impact on sudden death , 1990 .

[44]  S. Saksena.  Nonpharmacologic Therapy for Malignant Ventricular Tachyarrhythmias in Patients with Congestive Heart Failure , 1990 .

[45]  E. Gang,et al.  Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients. , 1990, American heart journal.

[46]  N. Rehnqvist.  Arrhythmias and their treatment in patients with heart failure. , 1989, The American journal of cardiology.

[47]  J. Johns,et al.  Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. , 1989, Journal of the American College of Cardiology.

[48]  A. Weyman,et al.  Programmed ventricular stimulation in patients with left ventricular dysfunction and ventricular tachycardia: effects of acute hemodynamic improvement due to nitroprusside. , 1989, Journal of the American College of Cardiology.

[49]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[50]  S. Gottlieb,et al.  The use of antiarrhythmic agents in heart failure: implications of CAST. , 1989, American heart journal.

[51]  B. Lown,et al.  Congestive heart failure induced by six of the newer antiarrhythmic drugs. , 1989, Journal of the American College of Cardiology.

[52]  S. Gottlieb.  Arrhythmias and sudden death in congestive heart failure , 1989 .

[53]  J. Miller,et al.  Risk stratification and management of patients with recurrent ventricular tachycardia and other malignant ventricular arrhythmias. , 1989, Circulation.

[54]  M. Kienzle,et al.  Induced Sustained Ventricular Tachycardia in Nonischemic Dilated Cardiomyopathy: Dependence on Clinical Presentation and Response to Antiarrhythmic Agents , 1989, Pacing and clinical electrophysiology : PACE.

[55]  D. Roden,et al.  Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study). , 1989, The American journal of cardiology.

[56]  J. G. Soldevila,et al.  Arritmias ventriculares espontáneas e inducidas por los medicamentos en la ICCV. Significado, pronóstico y tratamiento , 1989 .

[57]  J F Leclercq,et al.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[58]  P. Janský,et al.  Epidemiology of congestive heart failure. A review. , 1989, Cor et vasa.

[59]  W. Stevenson,et al.  Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. , 1988, American heart journal.

[60]  P. Tchou,et al.  Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. , 1988, Annals of internal medicine.

[61]  J. Ruskin,et al.  Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. , 1988, Journal of the American College of Cardiology.

[62]  C. Swerdlow,et al.  Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. , 1988, The American journal of cardiology.

[63]  P. Taggart,et al.  Monophasic action potentials at discontinuation of cardiopulmonary bypass: evidence for contraction-excitation feedback in man. , 1988, Circulation.

[64]  B. Lerman,et al.  Electrophysiological Evaluation of Sustained Ventricular Tachyarrhythmias in Idiopathic Dilated Cardiomyopathy , 1988, Pacing and clinical electrophysiology : PACE.

[65]  L. Horowitz,et al.  Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. , 1988, The American journal of cardiology.

[66]  E. Kinney.  Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. , 1988, The American journal of medicine.

[67]  W. Kannel,et al.  Cardiac failure and sudden death in the Framingham Study. , 1988, American heart journal.

[68]  B. Lown,et al.  Clinical predictors of arrhythmia worsening by antiarrhythmic drugs. , 1988, The American journal of cardiology.

[69]  J. Cleland,et al.  Arrhythmias, catecholamines and electrolytes. , 1988, The American journal of cardiology.

[70]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[71]  G. Breithardt,et al.  Direct operations for the management of life-threatening ischemic ventricular tachycardia. , 1987, The Journal of thoracic and cardiovascular surgery.

[72]  W. Parmley.  Factors causing arrhythmias in chronic congestive heart failure. , 1987, American Heart Journal.

[73]  B Lown,et al.  Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. , 1987, American heart journal.

[74]  J. Mason,et al.  Sudden death in idiopathic dilated cardiomyopathy. , 1987, Annals of internal medicine.

[75]  Bigger Jt.  Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. , 1987 .

[76]  J. Wilson.  Use of antiarrhythmic drugs in patients with heart failure: clinical efficacy, hemodynamic results, and relation to survival. , 1987, Circulation.

[77]  L. Mestroni,et al.  Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. , 1987, American heart journal.

[78]  H. Kay,et al.  Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. , 1987, The American journal of cardiology.

[79]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[80]  L. Horowitz,et al.  Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. , 1987, The American journal of cardiology.

[81]  F. Panetta.  Congestive heart failure. Pathophysiology and treatment. , 1987, Australian family physician.

[82]  M. Josephson,et al.  Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[83]  B. Gersh,et al.  The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. , 1986, Circulation.

[84]  J. Kjekshus,et al.  Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. , 1986, The American journal of cardiology.

[85]  R. Byington,et al.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. , 1986, Circulation.

[86]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[87]  G. Francis.  Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. , 1986, The American journal of cardiology.

[88]  J. Morganroth.  Management of ventricular arrhythmias in patients with congestive heart failure. Second case history presentation and panel discussion. , 1986, The American journal of cardiology.

[89]  W. Parmley,et al.  Congestive heart failure and arrhythmias: an overview. , 1986, The American journal of cardiology.

[90]  M. Packer,et al.  Sudden unexpected death in patients with congestive heart failure: a second frontier. , 1985, Circulation.

[91]  M. Gheorghiade,et al.  Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. , 1985, American heart journal.

[92]  P. Kligfield,et al.  Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. , 1985, The American journal of cardiology.

[93]  M. Josephson,et al.  Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. , 1984, Circulation.

[94]  A. Jaffe,et al.  Risk factors for sudden death after acute myocardial infarction: two-year follow-up. , 1984, The American journal of cardiology.

[95]  M. Moeschberger,et al.  Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.

[96]  J. A. Gomes,et al.  Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival. , 1984, Circulation.

[97]  T. LeJemtel,et al.  High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. , 1984, American heart journal.

[98]  T. Meinertz,et al.  Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1984, The American journal of cardiology.

[99]  J. Senges,et al.  Ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1984, British heart journal.

[100]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[101]  L. Horowitz,et al.  Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.

[102]  T. Sakurai,et al.  Sudden death in idiopathic cardiomyopathy. , 1983, Japanese circulation journal.

[103]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[104]  P. Denes,et al.  Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. , 1983, The American journal of cardiology.

[105]  R. Kehoe,et al.  Extended endocardial resection for the treatment of ventricular tachycardia and ventricular fibrillation. , 1982, The Annals of thoracic surgery.

[106]  E. Prystowsky,et al.  Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. , 1982, The American journal of cardiology.

[107]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[108]  B. Massie,et al.  Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.